Department of Pharmacology · School of Medicine, SUSTech

Haocheng Lu 鲁昊骋 · Ph.D.

Assistant Professor & Doctoral Supervisor · Guangdong Pearl River Young Talent

Investigating the mechanisms of vascular homeostasis and cardiometabolic disease, combining human genetics, multi-omics, and in vivo functional screening (CRISPR-MI) to identify therapeutic targets and pharmacological interventions.

Vascular Homeostasis Transcription Factor EB (TFEB) In Vivo CRISPR Screening Single-Cell & Multi-Omics Cardiovascular Pharmacology
Portrait of Haocheng Lu
School of Medicine, SUSTech Department of Pharmacology
SUSTech
56 Papers

NCBI Bibliography publications

Published in Circulation, Circ Res, Adv Sci, Sci Signal, AJHG, and more
5+ Grants

Principal Investigator Grants

NSFC General & Young Scientists Programs, Shenzhen Medical Academy, and more
2024 Year

Guangdong Pearl River Young Talent

School of Medicine, Southern University of Science and Technology

I · Profile

Connecting mechanism discovery with pharmacological intervention through vascular biology.

Dr. Haocheng Lu received his bachelor's degree in Clinical Medicine from Peking University Health Science Center, together with a dual bachelor's degree in Economics from the National School of Development, Peking University. He earned his Ph.D. in Physiology from the University of Michigan in 2019 and subsequently completed postdoctoral training in the Department of Internal Medicine at the University of Michigan. He is now an Assistant Professor in the Department of Pharmacology, School of Medicine, SUSTech.

His research centers on aortic aneurysm, atherosclerosis, metabolic dysfunction, and vascular cell homeostasis. The lab integrates human genetics, multi-omics maps, animal disease models, and pharmacological perturbation to link mechanistic discovery with translational validation.

Representative Mechanism Illustrations

Click any illustration to inspect high-resolution details or open the corresponding PubMed record.

Scientific illustration of TFEB activation protecting vascular smooth muscle cells and reducing abdominal aortic aneurysm formation
TFEB · AAA Circulation · 2020

Smooth Muscle TFEB Activation Prevents AAA

Identified the smooth muscle TFEB-BCL2 axis as protective in abdominal aortic aneurysm and proposed TFEB activation by cyclodextrin as an intervention strategy.

View on PubMed ↗
Scientific illustration of endothelial TFEB suppressing inflammation under laminar flow and reducing atherosclerosis
Endothelial TFEB Sci Signal · 2017

Endothelial TFEB Suppresses Inflammation & Atherosclerosis

Demonstrated that endothelial TFEB suppresses vascular inflammation, oxidative stress, and atherosclerosis.

View on PubMed ↗
Scientific illustration of CRISPR-MI and single-cell sequencing identifying TREM2-mediated macrophage mechanisms
CRISPR-MI · TREM2 Adv Sci · 2025

CRISPR-MI & scRNA-Seq Reveal TREM2 Function in AAA

Established the in vivo CRISPR-MI platform and integrated scRNA-seq to reveal TREM2 as a regulator of monocyte infiltration and macrophage apoptosis in AAA.

View on PubMed ↗

II · Research Pillars

Research Directions

Aortic Aneurysm & Vascular Remodeling

Aortic aneurysm mechanisms and therapeutic targets

We investigate aortic aneurysm, a highly lethal vascular dilation disease, focusing on how vascular smooth muscle cells, macrophages, perivascular adipose tissue, and genetic variants jointly drive lesion development and rupture risk.

  • Identified the smooth muscle TFEB-BCL2 axis as protective in abdominal aortic aneurysm and proposed TFEB activation by cyclodextrin as an intervention strategy.
  • Combined GWAS/TWAS with mechanistic studies to reveal the role of TCF7L2 in aortic aneurysm.
  • Characterized spatially distinct PVAT remodeling in response to AngII.
Aortic Aneurysm TFEB-BCL2 TCF7L2 PVAT
Atherosclerosis & Metabolism

Atherosclerosis and metabolic disease mechanisms

We study how shear stress, endothelial inflammation, lipid metabolism, and glucose metabolism reshape vascular homeostasis, with the goal of identifying molecular nodes connecting cardiovascular and metabolic disease.

  • First demonstrated that endothelial TFEB suppresses inflammation, oxidative stress, and atherosclerosis.
  • Showed that TFEB contributes to angiogenesis, insulin signaling, and systemic metabolic homeostasis.
  • Revealed how lipid-metabolism genes such as TM6SF2 affect cholesterol metabolism and diabetes-related phenotypes.
Shear Stress Endothelial Inflammation TFEB Lipid Metabolism
Drug Discovery & Translation

Cardiovascular drug discovery and technology translation

We develop in vivo functional screening strategies and validate therapeutic candidates in disease models, building a translational pipeline from high-throughput discovery to mechanistic intervention.

  • Established CRISPR-MI, an in vivo CRISPR screening platform for identifying disease-driving genes within complex lesions.
  • Integrated scRNA-seq to reveal TREM2 as a regulator of macrophage infiltration and apoptosis and as a potential AAA therapeutic target.
  • Studied LNP-mediated TFEB mRNA delivery and nitro-fatty acids in endothelial protection, inflammation resolution, and metabolic disease.
CRISPR-MI TREM2 LNP-mRNA Nitro-Fatty Acids

III · Publications

Selected & Recent Work

Our public NCBI bibliography includes 56 publications (updated October 26, 2026). Browse featured works, recent papers, reviews, or the complete list.

Bold Haocheng Lu # Co-first * Corresponding
Click any paper title for its PubMed record, or DOI for full text. 13 papers shown
IF 14.1

Adv Sci (Weinh).

Lu H, Xue C, Zhao Y, ..., Chen YE, Zhang J.
Full authors (31)

Lu H, Xue C, Zhao Y, Sun J, Zhao C, Zhang X, Zhao G, Liu Y, Liu H, Deng Y, Wang Y, Zhang C, Liu Y, Zeng L, Yang Y, Li B, Ding S, Zhou L, Kuang H, Wang Z, Ju W, Lin H, Lin J, Guo Y, Chang L, Zhao H, Wang J, Lin J, Zheng L, Chen YE, Zhang J.

IF 7.7

Am J Hum Genet.

Roychowdhury T#, Lu H#, Hornsby WE, ..., Garcia-Barrio MT, Willer CJ.
Full authors (41)

Roychowdhury T#, Lu H#, Hornsby WE, Crone B, Wang GT, Guo DC, Sendamarai AK, Devineni P, Lin M, Zhou W, Graham SE, Wolford BN, Surakka I, Wang Z, Chang L, Zhang J, Mathis M, Brummett CM, Melendez TL, Shea MJ, Kim KM, Deeb GM, Patel HJ, Eliason J, Eagle KA, Yang B, Ganesh SK, Brumpton B, Åsvold BO, Skogholt AH, Hveem K, VA Million Veteran Program, Pyarajan S, Klarin D, Tsao PS, Damrauer SM, Leal SM, Milewicz DM, Chen YE, Garcia-Barrio MT, Willer CJ.

Sci Transl Med.

Rom O, Liu Y, Liu Z, ..., Lu H, ..., Zhang J, Chen YE.
Full authors (33)

Rom O, Liu Y, Liu Z, Zhao Y, Wu J, Ghrayeb A, Villacorta L, Fan Y, Chang L, Wang L, Liu C, Yang D, Song J, Rech JC, Guo Y, Wang H, Zhao G, Liang W, Koike Y, Lu H, Koike T, Hayek T, Pennathur S, Xi C, Wen B, Sun D, Garcia-Barrio MT, Aviram M, Gottlieb E, Mor I, Liu W, Zhang J, Chen YE.

Nat Commun.

Surakka I, Fritsche LG, Zhou W, ..., Lu H, ..., Hveem K, Willer CJ.
Full authors (27)

Surakka I, Fritsche LG, Zhou W, Backman J, Kosmicki JA, Lu H, Brumpton B, Nielsen JB, Gabrielsen ME, Skogholt AH, Wolford B, Graham SE, Chen YE, Lee S, Kang HM, Langhammer A, Forsmo S, Åsvold BO, Styrkarsdottir U, Holm H, Gudbjartsson D, Stefansson K, Baras A, Regeneron Genetics Center, Abecasis GR, Hveem K, Willer CJ.

IV · Experience

Education & Experience

Current

School of Medicine, SUSTech

Assistant Professor / Associate Researcher, doctoral supervisor

Department of Internal Medicine, University of Michigan

Postdoctoral fellow, mentor: Prof. Y. Eugene Chen

Department of Physiology, University of Michigan

Ph.D., mentor: Prof. Y. Eugene Chen

Peking University Health Science Center / National School of Development

Bachelor of Clinical Medicine; dual bachelor's degree in Economics

V · Funding & Honors

Grants and Honors

Selected Grants

  • National Natural Science Foundation of China, General Program 82370490
    2024.1 - 2027.12 RMB 490,000
  • National Natural Science Foundation of China, Young Scientists Fund 32300958
    2024.1 - 2026.12 RMB 300,000
  • Shenzhen Medical Academy Young Investigator Program A032400515
    2025.1 - 2027.12 RMB 800,000
  • Guangdong Natural Science Foundation, General Program 2023A1515010489
    2023.1 - 2025.12 RMB 100,000
  • Shenzhen Basic Research Program JCYJ20240813100605008
    2024.11 - 2027.11 RMB 300,000

Honors

  • Guangdong Pearl River Young Talent 2024
  • American Heart Association Predoctoral Fellowship 2017 - 2019
  • Young Investigator Award
    AHA ATVB-PVD Scientific Sessions 2018
  • Gold Medal, International Biology Olympiad
    19th IBO, Mumbai, India 2008

VI · Contact

For research collaborations, student training, and academic exchanges.

Affiliation Department of Pharmacology, School of Medicine, SUSTech
Address 1088 Xueyuan Avenue, Nanshan District, Shenzhen, Guangdong, China